Director Market Access - Innovative products

Responsibilities

• Lead cross-functional launch project groups for all innovative products, collaborating with Medical Affairs, Public Affairs, and Commercial teams
• Develop and drive comprehensive Market Access strategies tailored to the German market to ensure launch readiness
• Lead the creation of AMNOG dossiers aligned with global and local brand strategies
• Shape and localize global value stories to strengthen product differentiation and prevent price erosion
• Execute evidence generation strategies to ensure payer and HTA requirements are met throughout the product lifecycle
• Create compelling payer value propositions and design innovative reimbursement mechanisms
• Partner with key payers to co-develop integrated solutions and value modules
• Represent the German affiliate in regional and global Market Access groups and meetings

Requirements

• Master's degree in Natural Sciences, Medicine, Health Economics, Public Health, Business Administration, or Law
• 5–7 years of professional experience in Market Access, pricing & reimbursement, or HTA within the pharmaceutical industry or related sectors
• Strong hands-on experience with AMNOG procedures and German benefit assessments (G-BA)
• Proven track record in successfully securing reimbursement for new, innovative products
• Solid background in evidence-based medicine, public health, or health economics
• Excellent communication skills in both German and English
• Strong stakeholder management skills and the ability to navigate complex environments

Benefits

• Competitive salary and attractive bonus & pension scheme
• Excellent career progression opportunities
• Work-life balance initiatives
• Health insurance

About the Company

Viatris is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, supplying high-quality medicines to approximately 1 billion patients annually.